• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Varian Buys Aspekt Solutions to Bolster Advanced Oncology Biz

    Patient Enrollment Ends in Biosense Webster's SmartfIRE Study

    New Data Shows Advantages of Rapid Medical’s COMANECI Embolization Assist Device

    Former FDA Director Joins Greenleaf Health

    Alexander D’Amico Named Chief Financial Officer at CytoSorbents
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Back to School for Medical Device Cybersecurity Training

    Driving Clinical Trial Excellence to Help Study Teams Run a Faster Relay Race

    Medtech’s Supply Chain: From Disruption to Opportunity

    Are Medtech’s Mega-Deals Gone For Good?

    Will a Skilling Gap Hinder Organizational Readiness for Medtech’s New Age of AI?
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Halkey-Roberts Corporation

    JBC Technologies

    NDH Medical Inc.

    LEMO USA Inc.

    Johari Digital Healthcare Ltd.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Wearables Are Changing the Way We Collect Real-World Data in Clinical Trials

    Could Medtech Ever Stop a Hospital Killer in Their Tracks?

    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Halkey-Roberts Corporation

    JBC Technologies

    NDH Medical Inc.

    LEMO USA Inc.

    Johari Digital Healthcare Ltd.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Globalization: Will Your 2019 Regulatory Strategy Help You Win in 2020?

    Successful medtech leaders have ongoing regulatory strategies for their respective businesses.

    Globalization: Will Your 2019 Regulatory Strategy Help You Win in 2020?
    Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors09.06.19
    Successful medtech leaders have ongoing regulatory strategies for their respective businesses. Mention the words “regulatory impacts” and most industry professionals immediately think of requirements for getting new products to market. But the most effective regulatory strategies involve evaluating the impacts of regulatory bodies on both existing and future products (regardless of whether the innovation is incremental or disruptive).

    As 2019 winds down and medtech firms begin their strategic planning for 2020, it’s important for companies to determine whether their current regulatory strategy will be a “winning” one next year. It remains to be seen whether 2020’s regulatory issues will be headwinds or tailwinds. While it certainly can be argued that regulatory issues are beyond a company’s control (due to the changing nature of governmental policies), we contend that strategizing against the competition is usually “graded on the curve.” Creating (and maintaining) international market access for products allows organizations to commercially execute their game plans. Without market access, there is no chance to compete and, therefore, no opportunity to win.

    And, synergistically, good portfolio management (a topic for a future MPO column) in medtech includes a regulatory strategy that considers the impacts of all present and future products.

    To begin the conversation on regulatory strategy, let’s consider some real-world challenges currently facing the medtech industry.

    Global Regulatory Challenge: MDR
    Possible Scenario A: A European firm with a solid product portfolio and significant sales history on the continent knows the ingredients for EU market success. Not surprisingly, each of its legacy EU products has its own CE mark; some are best sellers and some are “also-rans.” What are the strategic choices?
    1. Re-certify all products to the new MDR before the May 2020 deadline. Although recertification can be time consuming and create internal bandwidth challenges, it will allow the company to maintain a competitive edge with its EU product portfolio. There are risks, however. In some cases, the new MDR has re-classified some categories of products, which may impact a company’s ability to be re-certified in time. There also are fewer notified bodies now to complete the certification process.
    2. Use the MDR deadline as a “portfolio management” opportunity by recertifying only the best selling products and allowing the certification for “also-rans” to expire (leaving the market). Using this tactic can boost profitability through the elimination of unsuccessful items and the assurance of core product availability. Yet deciding on the SKUs to cut could be troublesome (a product might sell well in Italy, for example, but could be considered an “also-ran” in other parts of Europe). Companies executing this strategy risk upsetting customers (and sales reps), though. The menace of timely recertification also exists with this approach.
    3. Delay recertification to the new MDR altogether and only recertify to the existing MDD directives. While this option gives companies a four-year “breather” to maintain existing products and reassess their future portfolio strategy, rivals with MDR certification could use their compliance as a competitive advantage. One of the main risks with delaying MDR recertification is the market and customer uncertainty it likely will create.
    Possible Scenario B: A company is developing a new product and must decide where to launch it. Assuming the organization is global and has international market access, there are several obvious choices (related to regulatory impacts).
    1. Launch in the United States with U.S. Food and Drug Administration (FDA) clearance. This option gives the product access to one of the world’s largest markets; however, an American debut takes significant organizational focus, which could delay introductions in other parts of the world. Moreover, FDA clearance is not a “slam dunk,” as the agency is currently under pressure to revamp its existing 510(k) predicate device allowances. Thus, a de novo pathway may be necessary, leading to new clinical requirements.
    2. Launch in the EU under the new MDR. Companies that achieve this regulatory milestone will have a distinct competitive advantage because it is becoming increasingly clear that many medtech firms will not meet the deadline for recertification. Nevertheless, the EU is not one market—rather, it is a collection of 27 (28 if Great Britain is counted) distinct countries, each with their own languages and cultural differences that must be considered when introducing  products. As previously stated, the major risks with this strategy are finding qualified notified bodies and recertifying products before the deadline.
    3. Launch somewhere else in the world. Introducing a product somewhere other than America or Europe could eventually provide companies with the market and clinical data necessary for FDA and EU clearances. The major downside to this approach is that products will not be exposed to two of the world’s largest medtech markets. Companies also should keep in mind that many international markets (Japan, China, etc.) have more stringent, time-consuming requirements than the United States, thus imperilling any 2020 launch timelines.
    Global Regulatory Challenge: China
    Possible Scenario A: A company with products in the Chinese market should ideally update its portfolio to maintain its competitive advantage. However, the China NMPA (National Medical Products Administration) has replaced the former CFDA (which was previously the SFDA). Domestic companies are struggling with the requirements of the NMPA and its rules. What are the best strategic choices?
    1. File new product(s) with the NMPA and attempt to obtain clearance in 2020. Securing approval would provide a competitive advantage over other firms selling their wares in China (even some local companies). But such clearance is not attained easily—the NMPA requires new levels of clinical evidence that could be very costly. The main risk with this plan is IP protection—China has never really been the safest haven for proprietary technology, and with NMPA rules, companies may be required to disclose more proprietary data than which they are comfortable.
    2. Continue selling existing products and refresh the marketing and sales execution to maintain/grow market share. This plan allows companies to focus on their current product lines and potentially clears a path to incremental profitability next year; the only drawback lies in the innovation offered. By focusing on current products, companies are not providing Chinese customers with their best technology, and they are leaving themselves vulnerable to competitors who successfully navigate the China NMPA.
    Possible Scenario B: A company is not in the Chinese market but the Middle Kingdom is one of the best possible international growth opportunities for its products. Strategic choices include:
    1. File for NMPA clearance in 2020, thus gaining access to one of the world’s largest medtech markets. But, as previously noted, obtaining clearance in China can be complicated and costly; using resources in this way for an unknown market opportunity for products that may or may not be successful there is a risky venture.
    2. Enter the Chinese market at some future point. This tactic enables companies to focus on generating incremental sales and EBITDA in their core markets but locks them out of China—a risky move that can significantly hinder future growth prospects.
    Another key challenge (opportunity) companies should consider while evaluating their 2020 regulatory strategies include the IMDRF (International Medical Device Regulators Forum), a group of countries working together to attain regulatory harmonization. The countries/regions include the United States, Brazil, China, Canada, the EU, Japan, Russia, Singapore, South Korea, and Australia.

    While this initiative sounds promising, we remain skeptical about the ability of these regulatory bodies to play nice together. For example, the steps taken in the EU (with the new MDR) and in China (with the NMPA) seem contrary to the harmonization concept.

    We remain hopeful, however, that some of the players can find a way to actually harmonize their regulatory processes—i.e., creating easier international market access in the future. We’re not holding our breath but companies should stay tuned and take advantage if some positive results occur.

    Given the nature of this industry, the list of potential regulatory challenges could be a book. The previously mentioned issues are some of the most significant facing global businesses in the waning months of 2019. But they are not insurmountable. With the right strategy, these regulatory challenges can easily become competitive advantages. 


    Florence Joffroy-Black, CM&AA, is a longtime marketing and M&A expert with significant experience in the medical technology industry, including working for multi-national corporations based in the United States, Germany, and Israel. She is currently is CEO at MedWorld Advisors and can be reached at florencejblack@medworldadvisors.com.

    Dave Sheppard, CM&AA, is a former medical technology Fortune 500 executive and is now a Managing Director at MedWorld Advisors. He can be reached at davesheppard@medworldadvisors.com.  
    Related Searches
    • mpo
    • u.s. food and drug administration
    • clearance
    • japan
    Suggested For You
    Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021 MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021
    Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products
    Picarro Unveils EtO Gas Concentration Analyzer Picarro Unveils EtO Gas Concentration Analyzer
    Molli Surgical Molli Surgical's Breast Tumor Marker
    Luis J. Malavé Joins Integrity Applications Board Luis J. Malavé Joins Integrity Applications Board
    iNitrile iNitrile's Co-Founder Raises $33M for the Company
    Glooko’s Remote Patient Monitoring for Diabetics Glooko’s Remote Patient Monitoring for Diabetics
    Valencell’s Wearable Biomedical Sensors Valencell’s Wearable Biomedical Sensors
    Developing Next Generation Implants with Bioresorbables—A Medtech Makers Q&A Developing Next Generation Implants with Bioresorbables—A Medtech Makers Q&A
    Molding Modern Medtech Molding Modern Medtech
    FDA Clears 3NT Medical’s Peregrine Drivable ENT Scope FDA Clears 3NT Medical’s Peregrine Drivable ENT Scope
    Regulating IVDs and LDTs—Mike on Medtech Regulating IVDs and LDTs—Mike on Medtech
    Smaller Devices Require More Efficient Material Integration Smaller Devices Require More Efficient Material Integration
    Non-Profit Group Launches Initiative to Diversify Medtech Workforce Non-Profit Group Launches Initiative to Diversify Medtech Workforce

    Related Breaking News

    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      The two deals will strengthen Heraeus' healthcare and medtech portfolio.
      Heraeus 09.22.21

    • MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021

      MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021

      Attendees of The MedTech Conference, powered by AdvaMed, will vote for the Grand Prize winner.
      MedTech Innovator 09.21.21

    • Surgical
      Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products

      Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products

      Deliver consistent sealing reliability in an ergonomic, multifunctional design that promotes procedural efficiency.
      Olympus Corporation 09.21.21


    • Picarro Unveils EtO Gas Concentration Analyzer

      Picarro Unveils EtO Gas Concentration Analyzer

      Analyzers are now available for CEMS, stack testing, fenceline, and ambient monitoring systems.
      PR Newswire 09.20.21

    • Surgical
      Molli Surgical

      Molli Surgical's Breast Tumor Marker

      MPO's Sean Fenske speaks with Dr. Fazila Seker of MOLLI Surgical about the benefits of her company’s breast tumor marking system.
      Sean Fenske, Editor-in-Chief 09.14.21

    Loading, Please Wait..

    Trending
    • Cardiosense Begins SEISMIC-HF I Heart Failure Trial
    • Danaher Names New Environmental And Applied Solutions Company Veralto
    • Exo Introduces The Exo Iris To Market
    • A New Approach To Post-Market Surveillance
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    Breaking News
    • Zeus Introduces Absorv XSE Oriented Tubing
    • Laminate's VasQ Nabs De Novo Nod to Create AVFs for Dialysis Access
    • Varian Buys Aspekt Solutions to Bolster Advanced Oncology Biz
    • Patient Enrollment Ends in Biosense Webster's SmartfIRE Study
    • New Data Shows Advantages of Rapid Medical’s COMANECI Embolization Assist Device
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Superior Subtractive Solutions for Machining Medtech
    • Medical Device Industry Experts' Thought on Assembly & Automation
    • Power Trip: A Discussion of Custom Medical Electronics
    • The MDR Transition: An Opportunity for Design Change?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PLT Health Solutions Granted Claims for Botanical Ingredient in Canada
    CRN Files Petition with FTC For Clarity on Health Products Compliance Guidance
    Vitafoods Europe Relocates to Barcelona Starting 2025
    Coatings World

    Latest Breaking News From Coatings World

    Tim Knavish Elected PPG Chairman and CEO
    Alabama Students Gain Real-World Experience with Internships at BASF
    AkzoNobel Names Sweet Embrace as Interpon Color of the Year 2024
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    New Data Shows Advantages of Rapid Medical’s COMANECI Embolization Assist Device
    Former FDA Director Joins Greenleaf Health
    Alexander D’Amico Named Chief Financial Officer at CytoSorbents
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Ginkgo Bioworks, Pfizer Enter Multi-Target RNA Discovery Alliance
    WuXi Vaccines Launches Vaccines CDMO Site in China
    MilliporeSigma Launches Integrated mRNA Services
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    BASF and StitchCrew Introduce Educational Bootcamp for Indigenous Beauty Brands
    Top 10 Most Popular Fashion Designer Makeup Brands—According to Landys Chemist
    Jennifer Coolidge Collaborates with e.l.f. Cosmetics for 'Dirty Pillows' Lip Collection
    Happi

    Latest Breaking News From Happi

    Bio-Oil Launches 'Labor of Love' Campaign
    Wharton To Honor Leonard A. Lauder with Retail Excellence Award
    Extracts-Unlimited Attains Organic Certification
    Ink World

    Latest Breaking News From Ink World

    Sapphire Ink – SB Eco Series Receives Oeko-Tex Eco Passport ZDHC Level 3 Certification
    Flint Group Digital with Xeikon Present at FEFCO Technical Seminar
    R.E. Carroll Inc. Packs, Donates 400 Backpacks to Students
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Kodak launches PRINERGY 10.0
    UPM Raflatac receives new approval for linerless label printing
    UK flexo industry comes together at Apex LIVE
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ana Fraisse Joins The American Cleaning Institute
    Weekly Recap: Soft N' Dry Seeks to Expand Private Label Roll Out, Albis Completes Work on Line
    Lenzing Earns EU Ecolabel at Indonesian Plant
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ONWARD Completes First-in-Human for ARC-IM to Restore Upper Extremity Function
    Michael S. Aronow Installed as AOFAS President
    Abyrx's MONTAGE Settable Bone Putty Cleared for Cardiothoracic Surgery
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    PPG and Flō-Optics Enter Exclusive Supplier Agreement
    SEMI North America Advisory Board Adds New Members
    Nhat Tin Logistics Enhances Operations with Zebra Technologies

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login